Maravai Lifesciences Holdings (MRVI) Short term Debt: 2020-2025
Historic Short term Debt for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $5.4 million.
- Maravai Lifesciences Holdings' Short term Debt changed negligibly% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $5.4 million for FY2024, which is negligibly% changed negligibly from last year.
- Maravai Lifesciences Holdings' Short term Debt amounted to $5.4 million in Q3 2025, which was down 0.00% from $5.4 million recorded in Q2 2025.
- In the past 5 years, Maravai Lifesciences Holdings' Short term Debt registered a high of $42.3 million during Q1 2023, and its lowest value of $5.4 million during Q4 2022.
- Over the past 3 years, Maravai Lifesciences Holdings' median Short term Debt value was $5.4 million (recorded in 2025), while the average stood at $8.8 million.
- As far as peak fluctuations go, Maravai Lifesciences Holdings' Short term Debt skyrocketed by 480.63% in 2021, and later plummeted by 87.13% in 2024.
- Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Short term Debt stood at $34.8 million in 2021, then crashed by 84.38% to $5.4 million in 2022, then remained steady at $5.4 million in 2023, then remained steady at $5.4 million in 2024, then remained steady at $5.4 million in 2025.
- Its Short term Debt stands at $5.4 million for Q3 2025, versus $5.4 million for Q2 2025 and $5.4 million for Q1 2025.